HEADER HORMONE 02-SEP-09 2WRV TITLE SEMI-SYNTHETIC HIGHLY ACTIVE ANALOGUE OF HUMAN INSULIN NMEHISB26-DTI- TITLE 2 NH2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSULIN A CHAIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: INSULIN B CHAIN; COMPND 7 CHAIN: B; COMPND 8 FRAGMENT: RESIDUES 25-50; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606; SOURCE 6 MOL_ID: 2; SOURCE 7 SYNTHETIC: YES; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606 KEYWDS CARBOHYDRATE METABOLISM, GLUCOSE METABOLISM, HORMONE, ANALOGUE, KEYWDS 2 DIABETES MELLITUS EXPDTA X-RAY DIFFRACTION AUTHOR A.M.BRZOZOWSKI,J.JIRACEK,L.ZAKOVA,E.ANTOLIKOVA,C.J.WATSON, AUTHOR 2 J.P.TURKENBURG,G.G.DODSON REVDAT 5 20-DEC-23 2WRV 1 REMARK LINK REVDAT 4 30-AUG-17 2WRV 1 REMARK REVDAT 3 06-JUN-12 2WRV 1 JRNL REMARK REVDAT 2 13-JUL-11 2WRV 1 VERSN REVDAT 1 09-FEB-10 2WRV 0 JRNL AUTH J.JIRACEK,L.ZAKOVA,E.ANTOLIKOVA,C.J.WATSON,J.P.TURKENBURG, JRNL AUTH 2 G.G.DODSON,A.M.BRZOZOWSKI JRNL TITL IMPLICATIONS FOR THE ACTIVE FORM OF HUMAN INSULIN BASED ON JRNL TITL 2 THE STRUCTURAL CONVERGENCE OF HIGHLY ACTIVE HORMONE JRNL TITL 3 ANALOGUES. JRNL REF PROC.NATL.ACAD.SCI.USA V. 107 1966 2010 JRNL REFN ISSN 0027-8424 JRNL PMID 20133841 JRNL DOI 10.1073/PNAS.0911785107 REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0082 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.34 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 3 NUMBER OF REFLECTIONS : 2686 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.277 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.500 REMARK 3 FREE R VALUE TEST SET COUNT : 126 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.15 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.21 REMARK 3 REFLECTION IN BIN (WORKING SET) : 195 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.60 REMARK 3 BIN R VALUE (WORKING SET) : 0.2190 REMARK 3 BIN FREE R VALUE SET COUNT : 8 REMARK 3 BIN FREE R VALUE : 0.3940 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 363 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 4 REMARK 3 SOLVENT ATOMS : 45 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 24.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.64 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.10000 REMARK 3 B22 (A**2) : 0.10000 REMARK 3 B33 (A**2) : -0.20000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.277 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.239 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.147 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 13.073 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.940 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.911 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 374 ; 0.021 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 506 ; 1.677 ; 1.946 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 44 ; 7.273 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 19 ;42.253 ;24.737 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 58 ;16.425 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 1 ; 5.317 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 55 ; 0.135 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 289 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 229 ; 1.020 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 362 ; 1.835 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 145 ; 2.812 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 144 ; 4.422 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 21 REMARK 3 RESIDUE RANGE : B 2 B 26 REMARK 3 ORIGIN FOR THE GROUP (A): -10.4859 7.2819 -7.1897 REMARK 3 T TENSOR REMARK 3 T11: 0.0252 T22: 0.0250 REMARK 3 T33: 0.0249 T12: -0.0129 REMARK 3 T13: 0.0017 T23: 0.0030 REMARK 3 L TENSOR REMARK 3 L11: 1.3326 L22: 0.7513 REMARK 3 L33: 2.2624 L12: 0.3700 REMARK 3 L13: 0.0803 L23: 0.3560 REMARK 3 S TENSOR REMARK 3 S11: 0.1523 S12: -0.1018 S13: -0.0128 REMARK 3 S21: 0.0046 S22: -0.1075 S23: -0.0014 REMARK 3 S31: -0.1193 S32: 0.0686 S33: -0.0448 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES RESIDUAL REMARK 4 REMARK 4 2WRV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 02-SEP-09. REMARK 100 THE DEPOSITION ID IS D_1290041018. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-FEB-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.933 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 4113 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 37.340 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 7.200 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.19 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.4 REMARK 200 DATA REDUNDANCY IN SHELL : 7.00 REMARK 200 R MERGE FOR SHELL (I) : 0.26900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 6.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1MSO REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 NA CITRATE, 0.3 M TRIS PH 8.2, 0.6 REMARK 280 MM ZN ACETATE, 0.06% PHENOL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 41 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 3555 -Y,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X,Z+3/4 REMARK 290 5555 -X+1/2,Y,-Z+3/4 REMARK 290 6555 X,-Y+1/2,-Z+1/4 REMARK 290 7555 Y+1/2,X+1/2,-Z+1/2 REMARK 290 8555 -Y,-X,-Z REMARK 290 9555 X+1/2,Y+1/2,Z+1/2 REMARK 290 10555 -X,-Y,Z REMARK 290 11555 -Y+1/2,X,Z+3/4 REMARK 290 12555 Y,-X+1/2,Z+1/4 REMARK 290 13555 -X,Y+1/2,-Z+1/4 REMARK 290 14555 X+1/2,-Y,-Z+3/4 REMARK 290 15555 Y,X,-Z REMARK 290 16555 -Y+1/2,-X+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 19.58500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 19.58500 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 61.79650 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 19.58500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 30.89825 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 19.58500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 92.69475 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 19.58500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 92.69475 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 19.58500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 30.89825 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 19.58500 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 19.58500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 61.79650 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 1.000000 0.000000 0.000000 19.58500 REMARK 290 SMTRY2 9 0.000000 1.000000 0.000000 19.58500 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 61.79650 REMARK 290 SMTRY1 10 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 10 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 11 0.000000 -1.000000 0.000000 19.58500 REMARK 290 SMTRY2 11 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 1.000000 92.69475 REMARK 290 SMTRY1 12 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 12 -1.000000 0.000000 0.000000 19.58500 REMARK 290 SMTRY3 12 0.000000 0.000000 1.000000 30.89825 REMARK 290 SMTRY1 13 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 13 0.000000 1.000000 0.000000 19.58500 REMARK 290 SMTRY3 13 0.000000 0.000000 -1.000000 30.89825 REMARK 290 SMTRY1 14 1.000000 0.000000 0.000000 19.58500 REMARK 290 SMTRY2 14 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 14 0.000000 0.000000 -1.000000 92.69475 REMARK 290 SMTRY1 15 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 15 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 15 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 16 0.000000 -1.000000 0.000000 19.58500 REMARK 290 SMTRY2 16 -1.000000 0.000000 0.000000 19.58500 REMARK 290 SMTRY3 16 0.000000 0.000000 -1.000000 61.79650 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3790 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 5800 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -32.1 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -19.58500 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -30.89825 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN B, TYR 50 TO HS9 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PHE B 1 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 1022 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1HIT RELATED DB: PDB REMARK 900 INSULIN (HUMAN) MUTANT WITH PHE B 24 REPLACED BY GLY (F24G) (NMR, REMARK 900 REPRESENTATIVE PLUS 8 STRUCTURES) REMARK 900 RELATED ID: 2HHO RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT GLY- B8-SER, HIS-B10-ASP PRO- REMARK 900 B28-LYS, LYS- B29-PRO, 20 STRUCTURES REMARK 900 RELATED ID: 2C8Q RELATED DB: PDB REMARK 900 INSULINE(1SEC) AND UV LASER EXCITED FLUORESCENCE REMARK 900 RELATED ID: 1TYL RELATED DB: PDB REMARK 900 INSULIN (T3R3) (PH 6.4, 0.75 M NACL) COMPLEXED WITH TWO ZINC IONS REMARK 900 AND TYLENOL ( 4'-HYDROXYACETANILIDE) REMARK 900 RELATED ID: 2C8R RELATED DB: PDB REMARK 900 INSULINE(60SEC) AND UV LASER EXCITED FLUORESCENCE REMARK 900 RELATED ID: 1T1K RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B10-ASP, VAL-B12-ALA, REMARK 900 PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES REMARK 900 RELATED ID: 1AIY RELATED DB: PDB REMARK 900 R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 10 STRUCTURES REMARK 900 RELATED ID: 1HTV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF DESTRIPEPTIDE (B28-B30) INSULIN REMARK 900 RELATED ID: 1XDA RELATED DB: PDB REMARK 900 STRUCTURE OF INSULIN REMARK 900 RELATED ID: 1MSO RELATED DB: PDB REMARK 900 T6 HUMAN INSULIN AT 1.0 A RESOLUTION REMARK 900 RELATED ID: 1UZ9 RELATED DB: PDB REMARK 900 CRYSTALLOGRAPHIC AND SOLUTION STUDIES OF N- LITHOCHOLYL INSULIN: A REMARK 900 NEW GENERATION OF PROLONGED-ACTING INSULINS. REMARK 900 RELATED ID: 1FUB RELATED DB: PDB REMARK 900 FIRST PROTEIN STRUCTURE DETERMINED FROM X- RAY POWDERDIFFRACTION REMARK 900 DATA REMARK 900 RELATED ID: 1TYM RELATED DB: PDB REMARK 900 INSULIN (T3R3) (PH 5.6, 1.0 M NACL) COMPLEXED WITH TWO ZINC IONS REMARK 900 AND TYLENOL ( 4'-HYDROXYACETANILIDE) REMARK 900 RELATED ID: 1HUI RELATED DB: PDB REMARK 900 INSULIN MUTANT (B1, B10, B16, B27)GLU, DES -B30, NMR, 25 STRUCTURES REMARK 900 RELATED ID: 1VKT RELATED DB: PDB REMARK 900 HUMAN INSULIN TWO DISULFIDE MODEL, NMR, 10 STRUCTURES REMARK 900 RELATED ID: 2VK0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE FORM ULTALENTE INSULIN MICROCRYSTALS REMARK 900 RELATED ID: 1T1Q RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B10-ASP, VAL-B12-ABA, REMARK 900 PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES REMARK 900 RELATED ID: 1HLS RELATED DB: PDB REMARK 900 NMR STRUCTURE OF THE HUMAN INSULIN-HIS(B16 ) REMARK 900 RELATED ID: 2CEU RELATED DB: PDB REMARK 900 DESPENTAPEPTIDE INSULIN IN ACETIC ACID (PH 2 ) REMARK 900 RELATED ID: 1QJ0 RELATED DB: PDB REMARK 900 HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR REMARK 900 RELATED ID: 1FU2 RELATED DB: PDB REMARK 900 FIRST PROTEIN STRUCTURE DETERMINED FROM X- RAY POWDERDIFFRACTION REMARK 900 DATA REMARK 900 RELATED ID: 1MHJ RELATED DB: PDB REMARK 900 MOL_ID: 1; MOLECULE: INSULIN; CHAIN: A, B; ENGINEERED: YES MUTATION: REMARK 900 DES-[PHE(B 25)]; REMARK 900 RELATED ID: 1SJT RELATED DB: PDB REMARK 900 MINI-PROINSULIN, TWO CHAIN INSULIN ANALOG MUTANT: DES B30, HIS(B 10) REMARK 900 ASP, PRO(B 28)ASP, NMR, 20 STRUCTURES REMARK 900 RELATED ID: 1QIY RELATED DB: PDB REMARK 900 HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED REMARK 900 WITH PHENOL REMARK 900 RELATED ID: 1IOG RELATED DB: PDB REMARK 900 INSULIN MUTANT A3 GLY,(B1, B10, B16, B27) GLU, DES-B30, NMR, 19 REMARK 900 STRUCTURES REMARK 900 RELATED ID: 2VJZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE FORM ULTALENTE INSULIN MICROCRYSTALS REMARK 900 RELATED ID: 1IOH RELATED DB: PDB REMARK 900 INSULIN MUTANT A8 HIS,(B1, B10, B16, B27) GLU, DES-B30, NMR, 26 REMARK 900 STRUCTURES REMARK 900 RELATED ID: 1TRZ RELATED DB: PDB REMARK 900 INSULIN (T3R3) COMPLEX WITH TWO ZINC IONS REMARK 900 RELATED ID: 1EVR RELATED DB: PDB REMARK 900 THE STRUCTURE OF THE RESORCINOL/INSULIN R6 HEXAMER REMARK 900 RELATED ID: 1EV3 RELATED DB: PDB REMARK 900 STRUCTURE OF THE RHOMBOHEDRAL FORM OF THE M-CRESOL/INSULIN R6 REMARK 900 HEXAMER REMARK 900 RELATED ID: 1RWE RELATED DB: PDB REMARK 900 ENHANCING THE ACTIVITY OF INSULIN AT RECEPTOR EDGE: REMARK 900 CRYSTALSTRUCTURE AND PHOTO- CROSS-LINKING OF A8 ANALOGUES REMARK 900 RELATED ID: 1OS4 RELATED DB: PDB REMARK 900 DEHYDRATED T6 HUMAN INSULIN AT 295 K REMARK 900 RELATED ID: 1GUJ RELATED DB: PDB REMARK 900 INSULIN AT PH 2: STRUCTURAL ANALYSIS OF THE CONDITIONS PROMOTING REMARK 900 INSULIN FIBRE FORMATION. REMARK 900 RELATED ID: 1AI0 RELATED DB: PDB REMARK 900 R6 HUMAN INSULIN HEXAMER (NON-SYMMETRIC), NMR, 10 STRUCTURES REMARK 900 RELATED ID: 1JCO RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE MONOMERIC [THR(B27 )->PRO,PRO(B28)->THR] REMARK 900 INSULIN MUTANT (PT INSULIN) REMARK 900 RELATED ID: 1SF1 RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN UNDER AMYLOIDOGENICCONDITION, 15 REMARK 900 STRUCTURES REMARK 900 RELATED ID: 1JCA RELATED DB: PDB REMARK 900 NON-STANDARD DESIGN OF UNSTABLE INSULIN ANALOGUES WITHENHANCED REMARK 900 ACTIVITY REMARK 900 RELATED ID: 1ZEG RELATED DB: PDB REMARK 900 STRUCTURE OF B28 ASP INSULIN IN COMPLEX WITH PHENOL REMARK 900 RELATED ID: 1OS3 RELATED DB: PDB REMARK 900 DEHYDRATED T6 HUMAN INSULIN AT 100 K REMARK 900 RELATED ID: 1XGL RELATED DB: PDB REMARK 900 HUMAN INSULIN DISULFIDE ISOMER, NMR, 10 STRUCTURES REMARK 900 RELATED ID: 1T0C RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF HUMAN PROINSULIN C- PEPTIDE REMARK 900 RELATED ID: 1QIZ RELATED DB: PDB REMARK 900 HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED REMARK 900 WITH RESORCINOL REMARK 900 RELATED ID: 1G7B RELATED DB: PDB REMARK 900 1.3 A STRUCTURE OF T3R3 HUMAN INSULIN AT 100 K REMARK 900 RELATED ID: 2WBY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN INSULIN-DEGRADING ENZYME IN COMPLEX WITH REMARK 900 INSULIN REMARK 900 RELATED ID: 2AIY RELATED DB: PDB REMARK 900 R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 20 STRUCTURES REMARK 900 RELATED ID: 1EV6 RELATED DB: PDB REMARK 900 STRUCTURE OF THE MONOCLINIC FORM OF THE M -CRESOL/INSULIN R6 HEXAMER REMARK 900 RELATED ID: 1Q4V RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ALLO-ILEA2-INSULIN, AN INACTIVE CHIRALANALOGUE: REMARK 900 IMPLICATIONS FOR THE MECHANISM OF RECEPTOR REMARK 900 RELATED ID: 2HH4 RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT GLY- B8-D-SER, HIS-B10-ASP REMARK 900 PRO-B28-LYS, LYS -B29-PRO, 20 STRUCTURES REMARK 900 RELATED ID: 2H67 RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B5-ALA, HIS-B10-ASP PRO- REMARK 900 B28-LYS, LYS- B29-PRO, 20 STRUCTURES REMARK 900 RELATED ID: 4AIY RELATED DB: PDB REMARK 900 R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, ' GREEN' SUBSTATE, REMARK 900 AVERAGE STRUCTURE REMARK 900 RELATED ID: 1J73 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN UNSTABLE INSULIN ANALOG WITH NATIVEACTIVITY. REMARK 900 RELATED ID: 1K3M RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- A2-ALA, HIS-B10-ASP, PRO- REMARK 900 B28-LYS, LYS- B29-PRO, 15 STRUCTURES REMARK 900 RELATED ID: 1MHI RELATED DB: PDB REMARK 900 MOL_ID: 1; MOLECULE: INSULIN; CHAIN: A, B; ENGINEERED: YES MUTATION: REMARK 900 S(B 9)D; REMARK 900 RELATED ID: 2WC0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME IN COMPLEX WITH REMARK 900 IODINATED INSULIN REMARK 900 RELATED ID: 1KMF RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- A2-ALLO-ILE, HIS-B10-ASP, REMARK 900 PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES REMARK 900 RELATED ID: 2HIU RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN IN 20% ACETIC ACID, ZINC-FREE, 10 REMARK 900 STRUCTURES REMARK 900 RELATED ID: 1XW7 RELATED DB: PDB REMARK 900 DIABETES-ASSOCIATED MUTATIONS IN HUMAN INSULIN : CRYSTALSTRUCTURE REMARK 900 AND PHOTO-CROSS-LINKING STUDIES OF A-CHAINVARIANT INSULIN WAKAYAMA REMARK 900 RELATED ID: 5AIY RELATED DB: PDB REMARK 900 R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, ' RED' SUBSTATE, AVERAGE REMARK 900 STRUCTURE REMARK 900 RELATED ID: 1G7A RELATED DB: PDB REMARK 900 1.2 A STRUCTURE OF T3R3 HUMAN INSULIN AT 100 K REMARK 900 RELATED ID: 1ZNJ RELATED DB: PDB REMARK 900 INSULIN, MONOCLINIC CRYSTAL FORM REMARK 900 RELATED ID: 1ZEH RELATED DB: PDB REMARK 900 STRUCTURE OF INSULIN REMARK 900 RELATED ID: 1HIS RELATED DB: PDB REMARK 900 INSULIN (HUMAN, DES-PENTAPEPTIDE (B 26 - B 30)) (NMR, REMARK 900 REPRESENTATIVE PLUS 14 STRUCTURES) REMARK 900 RELATED ID: 1B9E RELATED DB: PDB REMARK 900 HUMAN INSULIN MUTANT SERB9GLU REMARK 900 RELATED ID: 3AIY RELATED DB: PDB REMARK 900 R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, REFINED AVERAGE STRUCTURE REMARK 900 RELATED ID: 1W8P RELATED DB: PDB REMARK 900 STRUCTURAL PROPERTIES OF THE B25TYR-NME- B26PHE INSULIN MUTANT. REMARK 900 RELATED ID: 1HIQ RELATED DB: PDB REMARK 900 INSULIN (HUMAN) MUTANT WITH PHE B 24 REPLACED BY SER (F24S) (NMR, REMARK 900 REPRESENTATIVE PLUS 9 STRUCTURES) REMARK 900 RELATED ID: 1EFE RELATED DB: PDB REMARK 900 AN ACTIVE MINI-PROINSULIN, M2PI REMARK 900 RELATED ID: 1LPH RELATED DB: PDB REMARK 900 LYS(B28)PRO(B29)-HUMAN INSULIN REMARK 900 RELATED ID: 1T1P RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- B10-ASP, VAL-B12-THR, REMARK 900 PRO-B28-LYS, LYS- B29-PRO, 15 STRUCTURES REMARK 900 RELATED ID: 1A7F RELATED DB: PDB REMARK 900 INSULIN MUTANT B16 GLU, B24 GLY, DES-B30 , NMR, 20 STRUCTURES REMARK 900 RELATED ID: 1BEN RELATED DB: PDB REMARK 900 INSULIN COMPLEXED WITH 4-HYDROXYBENZAMIDE REMARK 900 RELATED ID: 1LKQ RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- A2-GLY, VAL-A3-GLY, HIS- REMARK 900 B10-ASP, PRO- B28-LYS, LYS-B29-PRO, 20 STRUCTURES REMARK 900 RELATED ID: 2WS7 RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN PROB26-DTI REMARK 900 RELATED ID: 2WS0 RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMEALAB26-INSULIN AT PH 7.5 REMARK 900 RELATED ID: 2WS4 RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN PROB26-DTI IN MONOMER FORM REMARK 900 RELATED ID: 2WS1 RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMETYRB26-INSULIN IN REMARK 900 MONOMER FORM REMARK 900 RELATED ID: 2WS6 RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMETYRB26-INSULIN IN REMARK 900 HEXAMER FORM REMARK 900 RELATED ID: 2WRX RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC ANALOGUE OF HUMAN INSULIN NMEALAB26-INSULIN AT PH 3.0 REMARK 900 RELATED ID: 2WRW RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC HIGHLY ACTIVE ANALOGUE OF HUMAN INSULIN D-PROB26-DTI- REMARK 900 NH2 REMARK 900 RELATED ID: 2WRU RELATED DB: PDB REMARK 900 SEMI-SYNTHETIC HIGHLY ACTIVE ANALOGUE OF HUMAN INSULIN NMEALAB26- REMARK 900 DTI-NH2 REMARK 999 REMARK 999 SEQUENCE REMARK 999 B26 TYR MUTATED TO HIS, N ATOM OF B26 PEPTIDE IS REMARK 999 METHYLATED, B27-B30 ARE DELETED, B26 C-TERMINUS IS REMARK 999 FINISHED WITH CONH2 (CARBOXYAMIDE) NOT A COOH GROUP DBREF 2WRV A 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 2WRV B 1 26 UNP P01308 INS_HUMAN 25 50 SEQADV 2WRV HS9 B 26 UNP P01308 TYR 50 ENGINEERED MUTATION SEQRES 1 A 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 A 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 B 26 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 B 26 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE HS9 MODRES 2WRV HS9 B 26 HIS N-ALPHA-METHYL-L-HISTIDINAMIDE HET HS9 B 26 12 HET ACT A1022 4 HETNAM HS9 N-ALPHA-METHYL-L-HISTIDINAMIDE HETNAM ACT ACETATE ION HETSYN HS9 N-METHYL-L-HISTIDINAMIDE FORMUL 2 HS9 C7 H12 N4 O FORMUL 3 ACT C2 H3 O2 1- FORMUL 4 HOH *45(H2 O) HELIX 1 1 ILE A 2 CYS A 7 1 6 HELIX 2 2 SER A 12 ASN A 18 1 7 HELIX 3 3 SER B 9 CYS B 19 1 11 SSBOND 1 CYS A 6 CYS A 11 1555 1555 2.04 SSBOND 2 CYS A 7 CYS B 7 1555 1555 2.04 SSBOND 3 CYS A 20 CYS B 19 1555 1555 2.00 LINK C PHE B 25 N HS9 B 26 1555 1555 1.34 CISPEP 1 PHE B 25 HS9 B 26 0 2.36 SITE 1 AC1 1 HIS B 10 CRYST1 39.170 39.170 123.593 90.00 90.00 90.00 I 41 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025530 0.000000 0.000000 0.00000 SCALE2 0.000000 0.025530 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008091 0.00000 ATOM 1 N GLY A 1 -16.561 2.309 -15.560 1.00 10.39 N ATOM 2 CA GLY A 1 -15.255 2.955 -15.305 1.00 10.22 C ATOM 3 C GLY A 1 -15.177 3.457 -13.878 1.00 10.48 C ATOM 4 O GLY A 1 -15.857 2.959 -13.039 1.00 9.77 O ATOM 5 N ILE A 2 -14.358 4.469 -13.611 1.00 10.89 N ATOM 6 CA ILE A 2 -14.199 4.926 -12.267 1.00 11.37 C ATOM 7 C ILE A 2 -15.498 5.538 -11.701 1.00 12.90 C ATOM 8 O ILE A 2 -15.763 5.390 -10.524 1.00 12.69 O ATOM 9 CB ILE A 2 -12.978 5.908 -12.124 1.00 11.96 C ATOM 10 CG1 ILE A 2 -12.560 6.161 -10.643 1.00 8.96 C ATOM 11 CG2 ILE A 2 -13.184 7.190 -12.904 1.00 6.86 C ATOM 12 CD1 ILE A 2 -11.156 6.923 -10.502 1.00 8.39 C ATOM 13 N VAL A 3 -16.288 6.224 -12.520 1.00 12.63 N ATOM 14 CA VAL A 3 -17.493 6.851 -12.007 1.00 13.08 C ATOM 15 C VAL A 3 -18.489 5.764 -11.585 1.00 12.83 C ATOM 16 O VAL A 3 -19.056 5.835 -10.526 1.00 12.57 O ATOM 17 CB VAL A 3 -18.191 7.767 -13.059 1.00 13.53 C ATOM 18 CG1 VAL A 3 -19.452 8.421 -12.468 1.00 12.31 C ATOM 19 CG2 VAL A 3 -17.221 8.812 -13.648 1.00 12.01 C ATOM 20 N GLU A 4 -18.709 4.766 -12.414 1.00 12.87 N ATOM 21 CA GLU A 4 -19.568 3.710 -11.982 1.00 13.86 C ATOM 22 C GLU A 4 -19.058 3.043 -10.719 1.00 12.72 C ATOM 23 O GLU A 4 -19.808 2.809 -9.750 1.00 13.09 O ATOM 24 CB GLU A 4 -19.763 2.676 -13.080 1.00 14.50 C ATOM 25 CG GLU A 4 -21.091 1.895 -12.974 1.00 18.26 C ATOM 26 CD GLU A 4 -21.202 0.929 -14.125 1.00 25.37 C ATOM 27 OE1 GLU A 4 -20.265 1.040 -14.942 1.00 30.07 O ATOM 28 OE2 GLU A 4 -22.185 0.126 -14.262 1.00 23.27 O ATOM 29 N GLN A 5 -17.785 2.748 -10.709 1.00 11.39 N ATOM 30 CA GLN A 5 -17.198 2.018 -9.600 1.00 11.85 C ATOM 31 C GLN A 5 -17.062 2.718 -8.264 1.00 11.19 C ATOM 32 O GLN A 5 -17.232 2.071 -7.230 1.00 9.08 O ATOM 33 CB GLN A 5 -15.868 1.394 -10.003 1.00 12.26 C ATOM 34 CG GLN A 5 -16.026 0.059 -10.770 1.00 12.42 C ATOM 35 CD GLN A 5 -14.662 -0.560 -11.065 1.00 13.59 C ATOM 36 OE1 GLN A 5 -14.381 -0.994 -12.179 1.00 17.73 O ATOM 37 NE2 GLN A 5 -13.821 -0.570 -10.087 1.00 11.83 N ATOM 38 N CYS A 6 -16.780 4.024 -8.300 1.00 10.35 N ATOM 39 CA CYS A 6 -16.398 4.769 -7.106 1.00 12.18 C ATOM 40 C CYS A 6 -17.422 5.864 -6.690 1.00 12.59 C ATOM 41 O CYS A 6 -17.524 6.254 -5.503 1.00 11.60 O ATOM 42 CB CYS A 6 -14.955 5.375 -7.299 1.00 11.28 C ATOM 43 SG CYS A 6 -13.650 4.092 -7.385 1.00 13.95 S ATOM 44 N CYS A 7 -18.160 6.358 -7.684 1.00 11.85 N ATOM 45 CA CYS A 7 -19.142 7.391 -7.446 1.00 12.61 C ATOM 46 C CYS A 7 -20.551 6.829 -7.341 1.00 11.58 C ATOM 47 O CYS A 7 -21.203 7.015 -6.347 1.00 11.92 O ATOM 48 CB CYS A 7 -19.084 8.457 -8.577 1.00 11.38 C ATOM 49 SG CYS A 7 -20.355 9.714 -8.491 1.00 11.77 S ATOM 50 N THR A 8 -20.985 6.142 -8.392 1.00 11.76 N ATOM 51 CA THR A 8 -22.258 5.436 -8.429 1.00 10.96 C ATOM 52 C THR A 8 -22.274 4.369 -7.334 1.00 9.30 C ATOM 53 O THR A 8 -23.145 4.387 -6.490 1.00 6.56 O ATOM 54 CB THR A 8 -22.581 4.891 -9.835 1.00 11.03 C ATOM 55 OG1 THR A 8 -22.531 5.970 -10.770 1.00 12.49 O ATOM 56 CG2 THR A 8 -24.011 4.287 -9.903 1.00 11.57 C ATOM 57 N SER A 9 -21.272 3.484 -7.338 1.00 9.44 N ATOM 58 CA SER A 9 -21.044 2.584 -6.231 1.00 10.11 C ATOM 59 C SER A 9 -19.947 2.948 -5.206 1.00 10.25 C ATOM 60 O SER A 9 -19.524 4.073 -5.084 1.00 9.86 O ATOM 61 CB SER A 9 -20.811 1.166 -6.728 1.00 10.42 C ATOM 62 OG SER A 9 -21.824 0.774 -7.604 1.00 12.11 O ATOM 63 N ILE A 10 -19.585 1.992 -4.378 1.00 9.72 N ATOM 64 CA ILE A 10 -18.581 2.227 -3.403 1.00 10.45 C ATOM 65 C ILE A 10 -17.396 1.370 -3.834 1.00 11.23 C ATOM 66 O ILE A 10 -17.591 0.164 -4.101 1.00 12.40 O ATOM 67 CB ILE A 10 -19.090 1.879 -1.979 1.00 10.02 C ATOM 68 CG1 ILE A 10 -20.041 2.991 -1.519 1.00 10.10 C ATOM 69 CG2 ILE A 10 -17.920 1.830 -0.974 1.00 7.98 C ATOM 70 CD1 ILE A 10 -21.038 2.582 -0.405 1.00 5.74 C ATOM 71 N CYS A 11 -16.196 1.972 -3.951 1.00 10.61 N ATOM 72 CA CYS A 11 -15.001 1.211 -4.354 1.00 10.31 C ATOM 73 C CYS A 11 -13.941 1.090 -3.257 1.00 10.21 C ATOM 74 O CYS A 11 -13.884 1.889 -2.390 1.00 10.73 O ATOM 75 CB CYS A 11 -14.374 1.834 -5.604 1.00 9.69 C ATOM 76 SG CYS A 11 -13.564 3.472 -5.445 1.00 8.41 S ATOM 77 N SER A 12 -13.115 0.047 -3.295 1.00 12.29 N ATOM 78 CA SER A 12 -12.086 -0.158 -2.324 1.00 11.12 C ATOM 79 C SER A 12 -10.825 0.613 -2.714 1.00 11.42 C ATOM 80 O SER A 12 -10.762 1.251 -3.773 1.00 11.67 O ATOM 81 CB SER A 12 -11.816 -1.640 -2.175 1.00 10.36 C ATOM 82 OG SER A 12 -11.158 -2.130 -3.330 1.00 10.41 O ATOM 83 N LEU A 13 -9.821 0.563 -1.855 1.00 11.25 N ATOM 84 CA LEU A 13 -8.551 1.191 -2.165 1.00 12.12 C ATOM 85 C LEU A 13 -7.948 0.544 -3.382 1.00 12.02 C ATOM 86 O LEU A 13 -7.426 1.216 -4.236 1.00 12.68 O ATOM 87 CB LEU A 13 -7.584 1.099 -0.967 1.00 11.85 C ATOM 88 CG LEU A 13 -6.171 1.730 -1.037 1.00 10.29 C ATOM 89 CD1 LEU A 13 -6.157 3.183 -1.410 1.00 6.63 C ATOM 90 CD2 LEU A 13 -5.532 1.533 0.292 1.00 7.79 C ATOM 91 N TYR A 14 -8.010 -0.765 -3.417 1.00 13.63 N ATOM 92 CA TYR A 14 -7.434 -1.584 -4.454 1.00 14.89 C ATOM 93 C TYR A 14 -8.028 -1.229 -5.843 1.00 16.31 C ATOM 94 O TYR A 14 -7.277 -1.050 -6.821 1.00 16.65 O ATOM 95 CB TYR A 14 -7.733 -3.038 -4.140 1.00 14.18 C ATOM 96 CG TYR A 14 -7.309 -3.954 -5.243 1.00 17.85 C ATOM 97 CD1 TYR A 14 -8.166 -4.280 -6.285 1.00 20.62 C ATOM 98 CD2 TYR A 14 -6.024 -4.506 -5.256 1.00 21.21 C ATOM 99 CE1 TYR A 14 -7.746 -5.123 -7.316 1.00 23.19 C ATOM 100 CE2 TYR A 14 -5.604 -5.341 -6.269 1.00 19.99 C ATOM 101 CZ TYR A 14 -6.455 -5.646 -7.287 1.00 21.98 C ATOM 102 OH TYR A 14 -6.019 -6.468 -8.296 1.00 26.83 O ATOM 103 N GLN A 15 -9.368 -1.133 -5.929 1.00 15.82 N ATOM 104 CA GLN A 15 -10.071 -0.699 -7.134 1.00 15.64 C ATOM 105 C GLN A 15 -9.691 0.736 -7.514 1.00 15.98 C ATOM 106 O GLN A 15 -9.475 1.066 -8.662 1.00 16.51 O ATOM 107 CB GLN A 15 -11.573 -0.695 -6.865 1.00 15.27 C ATOM 108 CG GLN A 15 -12.249 -2.018 -6.964 1.00 12.54 C ATOM 109 CD GLN A 15 -13.679 -1.856 -6.630 1.00 12.96 C ATOM 110 OE1 GLN A 15 -14.037 -1.960 -5.477 1.00 12.11 O ATOM 111 NE2 GLN A 15 -14.498 -1.443 -7.611 1.00 12.95 N ATOM 112 N LEU A 16 -9.635 1.604 -6.539 1.00 15.42 N ATOM 113 CA LEU A 16 -9.280 2.967 -6.830 1.00 16.01 C ATOM 114 C LEU A 16 -7.853 3.124 -7.436 1.00 15.97 C ATOM 115 O LEU A 16 -7.713 3.822 -8.426 1.00 16.19 O ATOM 116 CB LEU A 16 -9.508 3.854 -5.603 1.00 15.25 C ATOM 117 CG LEU A 16 -9.249 5.341 -5.787 1.00 15.80 C ATOM 118 CD1 LEU A 16 -10.242 5.949 -6.758 1.00 16.15 C ATOM 119 CD2 LEU A 16 -9.336 6.021 -4.448 1.00 12.05 C ATOM 120 N GLU A 17 -6.852 2.447 -6.868 1.00 15.93 N ATOM 121 CA GLU A 17 -5.447 2.542 -7.294 1.00 15.83 C ATOM 122 C GLU A 17 -5.295 1.959 -8.657 1.00 16.84 C ATOM 123 O GLU A 17 -4.290 2.137 -9.274 1.00 16.27 O ATOM 124 CB GLU A 17 -4.500 1.807 -6.317 1.00 15.10 C ATOM 125 CG GLU A 17 -4.572 2.366 -4.972 1.00 12.19 C ATOM 126 CD GLU A 17 -3.642 1.756 -3.968 1.00 16.59 C ATOM 127 OE1 GLU A 17 -3.180 2.525 -3.077 1.00 16.21 O ATOM 128 OE2 GLU A 17 -3.371 0.514 -4.033 1.00 19.39 O ATOM 129 N ASN A 18 -6.298 1.243 -9.133 1.00 18.53 N ATOM 130 CA ASN A 18 -6.257 0.755 -10.503 1.00 20.05 C ATOM 131 C ASN A 18 -6.497 1.897 -11.575 1.00 19.19 C ATOM 132 O ASN A 18 -6.254 1.723 -12.777 1.00 18.14 O ATOM 133 CB ASN A 18 -7.240 -0.410 -10.640 1.00 21.38 C ATOM 134 CG ASN A 18 -6.579 -1.661 -11.217 1.00 26.22 C ATOM 135 OD1 ASN A 18 -6.587 -1.840 -12.448 1.00 29.68 O ATOM 136 ND2 ASN A 18 -5.982 -2.529 -10.338 1.00 27.20 N ATOM 137 N TYR A 19 -6.925 3.068 -11.100 1.00 17.50 N ATOM 138 CA TYR A 19 -7.150 4.223 -11.922 1.00 16.45 C ATOM 139 C TYR A 19 -6.062 5.238 -11.754 1.00 17.16 C ATOM 140 O TYR A 19 -6.176 6.375 -12.258 1.00 18.47 O ATOM 141 CB TYR A 19 -8.485 4.814 -11.560 1.00 16.44 C ATOM 142 CG TYR A 19 -9.598 3.910 -11.998 1.00 16.45 C ATOM 143 CD1 TYR A 19 -10.317 3.166 -11.080 1.00 15.01 C ATOM 144 CD2 TYR A 19 -9.879 3.747 -13.364 1.00 13.68 C ATOM 145 CE1 TYR A 19 -11.361 2.311 -11.509 1.00 15.71 C ATOM 146 CE2 TYR A 19 -10.888 2.920 -13.804 1.00 14.95 C ATOM 147 CZ TYR A 19 -11.638 2.187 -12.868 1.00 15.64 C ATOM 148 OH TYR A 19 -12.665 1.353 -13.318 1.00 15.37 O ATOM 149 N CYS A 20 -5.002 4.843 -11.041 1.00 15.56 N ATOM 150 CA CYS A 20 -3.764 5.576 -11.028 1.00 14.95 C ATOM 151 C CYS A 20 -2.987 5.333 -12.318 1.00 14.49 C ATOM 152 O CYS A 20 -3.060 4.251 -12.876 1.00 15.46 O ATOM 153 CB CYS A 20 -2.898 5.159 -9.831 1.00 14.49 C ATOM 154 SG CYS A 20 -3.645 5.554 -8.224 1.00 12.61 S ATOM 155 N ASN A 21 -2.235 6.340 -12.746 1.00 13.17 N ATOM 156 CA ASN A 21 -1.388 6.321 -13.912 1.00 11.13 C ATOM 157 C ASN A 21 -2.085 5.792 -15.106 1.00 9.69 C ATOM 158 O ASN A 21 -1.565 4.904 -15.758 1.00 9.27 O ATOM 159 CB ASN A 21 -0.137 5.490 -13.642 1.00 12.62 C ATOM 160 CG ASN A 21 0.919 5.701 -14.690 1.00 14.13 C ATOM 161 OD1 ASN A 21 1.050 6.796 -15.256 1.00 15.75 O ATOM 162 ND2 ASN A 21 1.664 4.661 -14.974 1.00 15.27 N ATOM 163 OXT ASN A 21 -3.177 6.206 -15.435 1.00 7.97 O TER 164 ASN A 21 ATOM 165 N VAL B 2 -21.382 7.894 7.025 1.00 26.91 N ATOM 166 CA VAL B 2 -20.814 8.953 6.136 1.00 25.83 C ATOM 167 C VAL B 2 -21.206 8.598 4.667 1.00 25.29 C ATOM 168 O VAL B 2 -21.624 7.459 4.396 1.00 24.71 O ATOM 169 CB VAL B 2 -19.269 9.098 6.370 1.00 26.12 C ATOM 170 CG1 VAL B 2 -18.401 8.083 5.530 1.00 25.29 C ATOM 171 CG2 VAL B 2 -18.801 10.508 6.089 1.00 27.77 C ATOM 172 N ASN B 3 -21.134 9.567 3.751 1.00 23.33 N ATOM 173 CA ASN B 3 -21.068 9.258 2.312 1.00 22.07 C ATOM 174 C ASN B 3 -19.739 8.568 1.939 1.00 20.96 C ATOM 175 O ASN B 3 -18.659 9.114 2.117 1.00 20.33 O ATOM 176 CB ASN B 3 -21.220 10.541 1.497 1.00 21.70 C ATOM 177 CG ASN B 3 -21.420 10.277 0.007 1.00 21.80 C ATOM 178 OD1 ASN B 3 -21.367 9.141 -0.447 1.00 19.42 O ATOM 179 ND2 ASN B 3 -21.675 11.343 -0.756 1.00 22.16 N ATOM 180 N GLN B 4 -19.847 7.374 1.398 1.00 19.88 N ATOM 181 CA GLN B 4 -18.702 6.591 1.010 1.00 18.99 C ATOM 182 C GLN B 4 -18.460 6.625 -0.482 1.00 17.06 C ATOM 183 O GLN B 4 -17.551 5.963 -1.005 1.00 15.71 O ATOM 184 CB GLN B 4 -18.884 5.164 1.477 1.00 19.87 C ATOM 185 CG GLN B 4 -18.780 5.053 2.963 1.00 22.64 C ATOM 186 CD GLN B 4 -18.811 3.633 3.351 1.00 27.98 C ATOM 187 OE1 GLN B 4 -19.880 3.055 3.669 1.00 27.82 O ATOM 188 NE2 GLN B 4 -17.663 3.001 3.220 1.00 30.77 N ATOM 189 N HIS B 5 -19.237 7.469 -1.140 1.00 15.03 N ATOM 190 CA HIS B 5 -19.095 7.666 -2.558 1.00 14.18 C ATOM 191 C HIS B 5 -18.068 8.747 -2.802 1.00 14.33 C ATOM 192 O HIS B 5 -17.997 9.733 -2.023 1.00 14.09 O ATOM 193 CB HIS B 5 -20.437 8.049 -3.172 1.00 12.93 C ATOM 194 CG HIS B 5 -21.478 7.007 -2.998 1.00 12.09 C ATOM 195 ND1 HIS B 5 -21.530 5.878 -3.781 1.00 11.92 N ATOM 196 CD2 HIS B 5 -22.497 6.903 -2.106 1.00 10.20 C ATOM 197 CE1 HIS B 5 -22.546 5.129 -3.382 1.00 11.34 C ATOM 198 NE2 HIS B 5 -23.160 5.739 -2.382 1.00 7.63 N ATOM 199 N LEU B 6 -17.319 8.584 -3.903 1.00 12.62 N ATOM 200 CA LEU B 6 -16.305 9.560 -4.288 1.00 11.54 C ATOM 201 C LEU B 6 -16.643 10.059 -5.663 1.00 11.27 C ATOM 202 O LEU B 6 -16.527 9.333 -6.624 1.00 11.07 O ATOM 203 CB LEU B 6 -14.906 8.866 -4.252 1.00 11.75 C ATOM 204 CG LEU B 6 -14.362 8.508 -2.848 1.00 8.90 C ATOM 205 CD1 LEU B 6 -13.168 7.521 -2.919 1.00 7.45 C ATOM 206 CD2 LEU B 6 -14.001 9.827 -2.033 1.00 6.12 C ATOM 207 N CYS B 7 -17.118 11.283 -5.767 1.00 12.36 N ATOM 208 CA CYS B 7 -17.618 11.828 -7.055 1.00 12.87 C ATOM 209 C CYS B 7 -17.009 13.182 -7.279 1.00 13.34 C ATOM 210 O CYS B 7 -16.848 13.901 -6.323 1.00 12.39 O ATOM 211 CB CYS B 7 -19.130 12.041 -7.011 1.00 11.89 C ATOM 212 SG CYS B 7 -20.107 10.597 -6.668 1.00 11.36 S ATOM 213 N GLY B 8 -16.706 13.527 -8.533 1.00 15.02 N ATOM 214 CA GLY B 8 -16.197 14.874 -8.876 1.00 16.19 C ATOM 215 C GLY B 8 -14.898 15.275 -8.188 1.00 16.60 C ATOM 216 O GLY B 8 -13.888 14.629 -8.318 1.00 15.58 O ATOM 217 N SER B 9 -14.932 16.356 -7.432 1.00 17.69 N ATOM 218 CA SER B 9 -13.720 16.853 -6.818 1.00 18.26 C ATOM 219 C SER B 9 -13.259 15.983 -5.657 1.00 18.27 C ATOM 220 O SER B 9 -12.074 15.925 -5.347 1.00 19.88 O ATOM 221 CB SER B 9 -13.918 18.301 -6.391 1.00 19.15 C ATOM 222 OG SER B 9 -14.658 18.396 -5.165 1.00 20.40 O ATOM 223 N HIS B 10 -14.172 15.269 -5.023 1.00 18.16 N ATOM 224 CA HIS B 10 -13.758 14.264 -4.036 1.00 17.37 C ATOM 225 C HIS B 10 -13.096 13.042 -4.656 1.00 16.33 C ATOM 226 O HIS B 10 -12.223 12.469 -4.059 1.00 15.08 O ATOM 227 CB HIS B 10 -14.910 13.886 -3.096 1.00 17.20 C ATOM 228 CG HIS B 10 -15.629 15.087 -2.557 1.00 18.64 C ATOM 229 ND1 HIS B 10 -16.885 15.450 -2.981 1.00 19.36 N ATOM 230 CD2 HIS B 10 -15.237 16.049 -1.684 1.00 17.80 C ATOM 231 CE1 HIS B 10 -17.246 16.573 -2.381 1.00 21.03 C ATOM 232 NE2 HIS B 10 -16.257 16.963 -1.603 1.00 18.80 N ATOM 233 N LEU B 11 -13.519 12.653 -5.854 1.00 15.36 N ATOM 234 CA LEU B 11 -12.843 11.601 -6.551 1.00 14.17 C ATOM 235 C LEU B 11 -11.459 12.027 -6.974 1.00 13.31 C ATOM 236 O LEU B 11 -10.509 11.253 -6.827 1.00 12.57 O ATOM 237 CB LEU B 11 -13.674 11.074 -7.727 1.00 14.42 C ATOM 238 CG LEU B 11 -13.233 9.780 -8.439 1.00 12.38 C ATOM 239 CD1 LEU B 11 -12.819 8.718 -7.459 1.00 5.94 C ATOM 240 CD2 LEU B 11 -14.306 9.346 -9.451 1.00 9.09 C ATOM 241 N VAL B 12 -11.353 13.247 -7.508 1.00 13.33 N ATOM 242 CA VAL B 12 -10.057 13.897 -7.812 1.00 13.03 C ATOM 243 C VAL B 12 -9.121 13.903 -6.600 1.00 13.75 C ATOM 244 O VAL B 12 -7.989 13.508 -6.732 1.00 14.52 O ATOM 245 CB VAL B 12 -10.263 15.379 -8.357 1.00 14.17 C ATOM 246 CG1 VAL B 12 -8.905 16.099 -8.641 1.00 11.57 C ATOM 247 CG2 VAL B 12 -11.124 15.346 -9.628 1.00 12.61 C ATOM 248 N GLU B 13 -9.595 14.350 -5.430 1.00 13.90 N ATOM 249 CA GLU B 13 -8.784 14.377 -4.231 1.00 15.00 C ATOM 250 C GLU B 13 -8.330 12.994 -3.771 1.00 13.66 C ATOM 251 O GLU B 13 -7.161 12.817 -3.408 1.00 14.30 O ATOM 252 CB GLU B 13 -9.498 15.163 -3.125 1.00 15.39 C ATOM 253 CG GLU B 13 -9.078 14.896 -1.640 1.00 21.38 C ATOM 254 CD GLU B 13 -7.559 14.840 -1.335 1.00 26.43 C ATOM 255 OE1 GLU B 13 -6.771 15.667 -1.882 1.00 27.40 O ATOM 256 OE2 GLU B 13 -7.172 13.945 -0.523 1.00 25.21 O ATOM 257 N ALA B 14 -9.226 12.024 -3.845 1.00 11.86 N ATOM 258 CA ALA B 14 -8.939 10.645 -3.473 1.00 12.02 C ATOM 259 C ALA B 14 -7.808 10.051 -4.336 1.00 11.34 C ATOM 260 O ALA B 14 -6.989 9.306 -3.877 1.00 11.88 O ATOM 261 CB ALA B 14 -10.271 9.745 -3.526 1.00 10.48 C ATOM 262 N LEU B 15 -7.828 10.377 -5.603 1.00 11.45 N ATOM 263 CA LEU B 15 -6.797 10.000 -6.513 1.00 13.36 C ATOM 264 C LEU B 15 -5.442 10.726 -6.246 1.00 13.49 C ATOM 265 O LEU B 15 -4.426 10.060 -6.130 1.00 12.55 O ATOM 266 CB LEU B 15 -7.281 10.184 -7.974 1.00 12.05 C ATOM 267 CG LEU B 15 -8.289 9.188 -8.539 1.00 12.97 C ATOM 268 CD1 LEU B 15 -9.112 9.801 -9.685 1.00 10.75 C ATOM 269 CD2 LEU B 15 -7.704 7.827 -8.894 1.00 7.52 C ATOM 270 N TYR B 16 -5.432 12.052 -6.128 1.00 14.64 N ATOM 271 CA TYR B 16 -4.226 12.739 -5.556 1.00 18.32 C ATOM 272 C TYR B 16 -3.536 11.983 -4.401 1.00 16.91 C ATOM 273 O TYR B 16 -2.359 11.694 -4.454 1.00 15.39 O ATOM 274 CB TYR B 16 -4.553 14.158 -5.042 1.00 18.96 C ATOM 275 CG TYR B 16 -4.128 15.202 -5.999 1.00 27.11 C ATOM 276 CD1 TYR B 16 -2.769 15.534 -6.151 1.00 32.78 C ATOM 277 CD2 TYR B 16 -5.087 15.865 -6.813 1.00 32.77 C ATOM 278 CE1 TYR B 16 -2.388 16.516 -7.105 1.00 37.53 C ATOM 279 CE2 TYR B 16 -4.723 16.849 -7.734 1.00 34.12 C ATOM 280 CZ TYR B 16 -3.387 17.158 -7.888 1.00 38.15 C ATOM 281 OH TYR B 16 -3.061 18.139 -8.802 1.00 45.13 O ATOM 282 N LEU B 17 -4.329 11.759 -3.352 1.00 16.67 N ATOM 283 CA LEU B 17 -3.996 11.018 -2.183 1.00 15.80 C ATOM 284 C LEU B 17 -3.358 9.657 -2.449 1.00 15.23 C ATOM 285 O LEU B 17 -2.221 9.396 -2.032 1.00 14.68 O ATOM 286 CB LEU B 17 -5.280 10.814 -1.340 1.00 15.80 C ATOM 287 CG LEU B 17 -5.088 10.123 0.044 1.00 15.47 C ATOM 288 CD1 LEU B 17 -4.114 10.858 0.958 1.00 11.85 C ATOM 289 CD2 LEU B 17 -6.393 9.971 0.719 1.00 15.23 C ATOM 290 N VAL B 18 -4.120 8.775 -3.070 1.00 14.54 N ATOM 291 CA VAL B 18 -3.741 7.361 -3.127 1.00 15.41 C ATOM 292 C VAL B 18 -2.733 7.100 -4.216 1.00 16.11 C ATOM 293 O VAL B 18 -1.975 6.196 -4.095 1.00 16.64 O ATOM 294 CB VAL B 18 -4.979 6.381 -3.200 1.00 14.96 C ATOM 295 CG1 VAL B 18 -6.044 6.852 -2.232 1.00 15.07 C ATOM 296 CG2 VAL B 18 -5.544 6.262 -4.608 1.00 14.07 C ATOM 297 N CYS B 19 -2.697 7.924 -5.264 1.00 17.24 N ATOM 298 CA CYS B 19 -1.846 7.652 -6.430 1.00 17.99 C ATOM 299 C CYS B 19 -0.468 8.221 -6.205 1.00 19.70 C ATOM 300 O CYS B 19 0.514 7.729 -6.746 1.00 19.55 O ATOM 301 CB CYS B 19 -2.458 8.231 -7.729 1.00 16.96 C ATOM 302 SG CYS B 19 -4.000 7.519 -8.223 1.00 12.83 S ATOM 303 N GLY B 20 -0.413 9.260 -5.377 1.00 21.41 N ATOM 304 CA GLY B 20 0.870 9.883 -4.993 1.00 22.72 C ATOM 305 C GLY B 20 1.688 10.268 -6.215 1.00 23.10 C ATOM 306 O GLY B 20 1.202 10.969 -7.103 1.00 21.45 O ATOM 307 N GLU B 21 2.919 9.756 -6.257 1.00 24.60 N ATOM 308 CA GLU B 21 3.906 10.182 -7.208 1.00 25.55 C ATOM 309 C GLU B 21 3.663 9.629 -8.593 1.00 26.14 C ATOM 310 O GLU B 21 3.900 10.327 -9.577 1.00 25.77 O ATOM 311 CB GLU B 21 5.287 9.860 -6.699 1.00 26.05 C ATOM 312 CG GLU B 21 6.248 10.967 -7.079 1.00 29.66 C ATOM 313 CD GLU B 21 7.364 11.217 -6.077 1.00 32.79 C ATOM 314 OE1 GLU B 21 7.053 11.401 -4.882 1.00 34.40 O ATOM 315 OE2 GLU B 21 8.553 11.283 -6.502 1.00 35.60 O ATOM 316 N ARG B 22 3.155 8.389 -8.658 1.00 26.65 N ATOM 317 CA ARG B 22 2.538 7.834 -9.872 1.00 26.73 C ATOM 318 C ARG B 22 1.707 8.833 -10.713 1.00 25.56 C ATOM 319 O ARG B 22 1.754 8.797 -11.924 1.00 25.71 O ATOM 320 CB ARG B 22 1.559 6.696 -9.501 1.00 27.41 C ATOM 321 CG ARG B 22 2.157 5.348 -8.997 1.00 30.04 C ATOM 322 CD ARG B 22 1.122 4.646 -8.079 1.00 35.81 C ATOM 323 NE ARG B 22 0.185 3.701 -8.733 1.00 34.71 N ATOM 324 CZ ARG B 22 -0.830 3.093 -8.107 1.00 34.34 C ATOM 325 NH1 ARG B 22 -1.098 3.344 -6.802 1.00 36.08 N ATOM 326 NH2 ARG B 22 -1.597 2.240 -8.788 1.00 34.47 N ATOM 327 N GLY B 23 0.866 9.638 -10.058 1.00 23.83 N ATOM 328 CA GLY B 23 -0.077 10.518 -10.737 1.00 20.83 C ATOM 329 C GLY B 23 -1.277 9.774 -11.279 1.00 19.30 C ATOM 330 O GLY B 23 -1.399 8.575 -11.134 1.00 17.18 O ATOM 331 N PHE B 24 -2.155 10.518 -11.942 1.00 18.58 N ATOM 332 CA PHE B 24 -3.419 10.011 -12.411 1.00 16.82 C ATOM 333 C PHE B 24 -4.045 10.874 -13.538 1.00 17.27 C ATOM 334 O PHE B 24 -3.804 12.086 -13.625 1.00 16.73 O ATOM 335 CB PHE B 24 -4.398 9.939 -11.221 1.00 16.79 C ATOM 336 CG PHE B 24 -4.828 11.268 -10.704 1.00 15.32 C ATOM 337 CD1 PHE B 24 -4.072 11.921 -9.735 1.00 14.01 C ATOM 338 CD2 PHE B 24 -6.017 11.849 -11.155 1.00 13.00 C ATOM 339 CE1 PHE B 24 -4.435 13.170 -9.267 1.00 10.01 C ATOM 340 CE2 PHE B 24 -6.454 13.088 -10.670 1.00 14.05 C ATOM 341 CZ PHE B 24 -5.642 13.761 -9.703 1.00 14.80 C ATOM 342 N PHE B 25 -4.872 10.259 -14.385 1.00 15.59 N ATOM 343 CA PHE B 25 -5.646 11.020 -15.339 1.00 15.12 C ATOM 344 C PHE B 25 -6.895 11.521 -14.639 1.00 15.56 C ATOM 345 O PHE B 25 -7.541 10.768 -13.921 1.00 13.85 O ATOM 346 CB PHE B 25 -5.979 10.147 -16.509 1.00 13.85 C ATOM 347 CG PHE B 25 -6.768 10.820 -17.560 1.00 13.69 C ATOM 348 CD1 PHE B 25 -8.133 10.569 -17.679 1.00 9.09 C ATOM 349 CD2 PHE B 25 -6.149 11.684 -18.473 1.00 10.54 C ATOM 350 CE1 PHE B 25 -8.889 11.208 -18.645 1.00 10.08 C ATOM 351 CE2 PHE B 25 -6.905 12.312 -19.460 1.00 11.23 C ATOM 352 CZ PHE B 25 -8.296 12.043 -19.540 1.00 9.87 C HETATM 353 N HS9 B 26 -7.198 12.817 -14.774 1.00 17.19 N HETATM 354 CA HS9 B 26 -6.429 13.792 -15.600 1.00 18.50 C HETATM 355 CB HS9 B 26 -7.347 14.391 -16.729 1.00 18.49 C HETATM 356 CG HS9 B 26 -6.690 15.422 -17.619 1.00 19.14 C HETATM 357 ND1 HS9 B 26 -5.347 15.384 -17.972 1.00 19.29 N HETATM 358 CD2 HS9 B 26 -7.200 16.527 -18.223 1.00 16.78 C HETATM 359 CE1 HS9 B 26 -5.061 16.418 -18.750 1.00 14.84 C HETATM 360 NE2 HS9 B 26 -6.169 17.124 -18.924 1.00 16.67 N HETATM 361 C HS9 B 26 -5.897 14.874 -14.635 1.00 19.08 C HETATM 362 O HS9 B 26 -6.412 15.992 -14.561 1.00 17.94 O HETATM 363 NXT HS9 B 26 -4.961 14.634 -13.861 1.00 19.69 N HETATM 364 CM HS9 B 26 -8.184 13.194 -14.185 1.00 19.78 C TER 365 HS9 B 26 HETATM 366 C ACT A1022 -20.199 18.558 -0.834 0.25 41.36 C HETATM 367 O ACT A1022 -20.979 17.628 -0.527 0.25 41.24 O HETATM 368 OXT ACT A1022 -19.235 18.746 -0.058 0.25 41.25 O HETATM 369 CH3 ACT A1022 -20.408 19.391 -2.065 0.25 41.33 C HETATM 370 O HOH A2001 -9.874 6.633 -14.993 0.50 6.84 O HETATM 371 O HOH A2002 -12.623 5.293 -15.823 1.00 11.36 O HETATM 372 O HOH A2003 -23.630 10.771 -8.077 1.00 19.99 O HETATM 373 O HOH A2004 -11.082 -0.960 -10.604 1.00 27.85 O HETATM 374 O HOH A2005 -9.904 -6.127 -3.078 1.00 22.29 O HETATM 375 O HOH A2006 -16.292 4.932 -3.383 1.00 9.72 O HETATM 376 O HOH A2007 -22.866 8.987 -5.544 1.00 16.14 O HETATM 377 O HOH A2008 -23.522 7.978 -10.328 1.00 20.20 O HETATM 378 O HOH A2009 -22.855 4.994 -13.440 1.00 32.51 O HETATM 379 O HOH A2010 -14.268 2.173 0.239 1.00 25.70 O HETATM 380 O HOH A2011 -12.235 -4.546 -3.720 1.00 18.58 O HETATM 381 O HOH A2012 -4.839 -2.077 -7.518 1.00 17.75 O HETATM 382 O HOH A2013 -8.480 -2.598 -1.033 1.00 12.60 O HETATM 383 O HOH A2014 -15.947 -2.193 -3.445 1.00 12.45 O HETATM 384 O HOH A2015 -7.040 0.782 -14.937 1.00 19.62 O HETATM 385 O HOH A2016 -9.804 -0.932 -12.945 1.00 36.48 O HETATM 386 O HOH A2017 -5.209 7.541 -14.365 1.00 6.25 O HETATM 387 O HOH A2018 -2.990 1.759 -11.900 1.00 23.20 O HETATM 388 O HOH A2019 0.356 9.663 -14.585 1.00 17.72 O HETATM 389 O HOH B2001 -22.250 10.987 -3.658 1.00 22.06 O HETATM 390 O HOH B2002 -24.245 10.931 3.903 1.00 36.41 O HETATM 391 O HOH B2003 -22.316 6.078 1.228 1.00 12.88 O HETATM 392 O HOH B2004 -20.351 12.314 -11.040 1.00 26.40 O HETATM 393 O HOH B2005 -12.490 15.564 -0.208 1.00 21.43 O HETATM 394 O HOH B2006 -25.503 4.654 -1.139 1.00 17.68 O HETATM 395 O HOH B2007 -18.013 12.309 -3.289 1.00 18.53 O HETATM 396 O HOH B2008 2.067 9.248 -1.860 1.00 26.96 O HETATM 397 O HOH B2009 -17.512 11.864 -10.734 1.00 12.75 O HETATM 398 O HOH B2010 5.989 14.578 -6.537 1.00 36.06 O HETATM 399 O HOH B2011 -11.658 17.837 -3.441 1.00 23.56 O HETATM 400 O HOH B2012 -17.916 18.152 -7.151 1.00 31.73 O HETATM 401 O HOH B2013 -11.559 12.888 -1.142 1.00 11.14 O HETATM 402 O HOH B2014 -10.524 19.379 -13.157 1.00 36.61 O HETATM 403 O HOH B2015 -3.628 16.113 -11.463 1.00 29.22 O HETATM 404 O HOH B2016 -0.295 10.603 -0.751 1.00 4.57 O HETATM 405 O HOH B2017 0.880 7.323 -2.702 1.00 16.90 O HETATM 406 O HOH B2018 2.540 6.172 -4.866 1.00 38.67 O HETATM 407 O HOH B2019 2.942 13.194 -5.338 1.00 21.28 O HETATM 408 O HOH B2020 -1.253 11.816 -7.345 1.00 12.94 O HETATM 409 O HOH B2021 4.311 9.112 -3.567 1.00 23.70 O HETATM 410 O HOH B2022 8.661 14.000 -7.414 1.00 29.75 O HETATM 411 O HOH B2023 -1.510 13.703 -12.576 1.00 20.40 O HETATM 412 O HOH B2024 -8.369 8.246 -13.489 1.00 9.61 O HETATM 413 O HOH B2025 -9.016 17.125 -13.187 1.00 31.78 O HETATM 414 O HOH B2026 -3.022 13.007 -17.448 1.00 17.81 O CONECT 43 76 CONECT 49 212 CONECT 76 43 CONECT 154 302 CONECT 212 49 CONECT 302 154 CONECT 344 353 CONECT 353 344 354 364 CONECT 354 353 355 361 CONECT 355 354 356 CONECT 356 355 357 358 CONECT 357 356 359 CONECT 358 356 360 CONECT 359 357 360 CONECT 360 358 359 CONECT 361 354 362 363 CONECT 362 361 CONECT 363 361 CONECT 364 353 CONECT 366 367 368 369 CONECT 367 366 CONECT 368 366 CONECT 369 366 MASTER 534 0 2 3 0 0 1 6 412 2 23 4 END